Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory DiseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study characterized the airway resistome, the collection of antibiotic resistance genes in the airway, and linked it to host microbiomes. Researchers used ultradeep metagenomic shotgun sequencing of sputum, averaging over 20 million reads per sample. Resistance genes were annotated against the Comprehensive Antibiotic Resistance Database. Gene-microbe co-occurrence networks identified likely microbial sources. Paired patient-inhaler swabs were compared to test airway-environment overlap.
Who was studied?
The main cohort was 85 people in Singapore. It included 13 nondiseased healthy individuals, 11 with severe asthma, 15 with COPD, and 15 with bronchiectasis. Healthy participants were younger, around 34 years, versus roughly 64 to 70 in the disease groups. Healthy individuals had no inhaled medication or antibiotic use in the prior 12 months. A separate cohort provided 31 paired airway-and-inhaler specimens (16 severe asthma, 11 COPD, 4 bronchiectasis).
What were the most important findings?
A core resistome of 18 antibiotic resistance genes appeared in every individual, including healthy and antibiotic-naive people. It was dominated by macrolide resistance genes (mel/msrD, ermB, ermF, ermX) plus tetracycline (tetW, tetO), beta-lactam, and fluoroquinolone genes. This core resistome was independent of disease status and recent antibiotic exposure. COPD patients harbored the highest diversity of resistance genes. Paired airway and inhaler specimens showed significant overlap, with 80 shared microbial taxa and 53 shared resistance genes, suggesting inhalers act as resistance reservoirs.
What are the greatest implications of this study?
A persistent core macrolide resistome in the healthy airway may help explain why pathogens are not always eradicated by appropriate antibiotics. It raises caution about expanding long-term macrolide use in chronic respiratory disease. Inhaler devices may serve as a surrogate for the airway microbiome and as a reservoir for resistance transfer. The study is cross-sectional with only 85 individuals and younger healthy controls, so longitudinal validation is needed.